SCHEMBL14564247

SCHEMBL14564247

CC(C)CCCC(C)C1CCC2C3CC=C4CC(OC(=O)CCC(=O)NCCN)CCC4(C)C3CCC12C

nearest known ligand 0.82

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ POLA1 P09884 1/20 0.65
▸ CYP46A1 Q9Y6A2 2/20 0.64
▸ PLA2G2A P14555 1/20 0.60
▸ USP2 O75604 2/20 0.59
▸ LMNA P02545 1/20 0.59
▸ ABCB1 P08183 1/20 0.59
▸ OSBP P22059 1/20 0.59
▸ RORC P51449 1/20 0.59
▸ OSBP2 Q969R2 1/20 0.59
▸ NR1H3 Q13133 3/20 0.56
▸ NPC1 O15118 1/20 0.55
▸ NPC1L1 Q9UHC9 2/20 0.53
▸ FGF2 P09038 1/20 0.52
▸ GBA1 P04062 2/20 0.52
▸ UGCG Q16739 2/20 0.52
▸ GBA2 Q9HCG7 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23876215 0.95 POLA1 (0.68) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL12325985 0.94 CYP46A1 (0.68) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL30862604 0.91 POLA1 (0.72) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL22292573 0.91 POLA1 (0.72) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL33528291 0.91 POLA1 (0.72) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL26910780 0.91 POLA1 (0.77) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL330612 0.91 POLA1 (0.77) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL25992010 0.91 POLA1 (0.62) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL20620339 0.91 POLA1 (0.62) POLA1CYP46A1PLA2G2AUSP2LMNA
SCHEMBL15371975 0.91 POLA1 (0.70) POLA1CYP46A1PLA2G2AUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1764089-A1 Serum stable liposomes comprising amphoter II lipid mixtures Novosom AG (DE) 2007-03-21 — — EP disclosed
Send feedback